Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1347509 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA | CTD | PMID:22079256 | 1'-acetoxychavicol acetate | multiple interactions | ISO | RGD:1347509 | 6480464 | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | CTD | PMID:15905586 | 1,3-dinitrobenzene | increases expression | ISO | RGD:620847 | 6480464 | 3-dinitrobenzene results in increased expression of CFLAR mRNA | CTD | PMID:22841810 | 17beta-estradiol | affects expression | ISO | RGD:1347509 | 6480464 | Estradiol affects the expression of CFLAR mRNA | CTD | PMID:21826169 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA | CTD | PMID:12167310 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620847 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CFLAR mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:620847 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA | CTD | PMID:19520675 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CFLAR protein; more ... | CTD | PMID:18334599 | 2,4-dinitrotoluene | affects expression | ISO | RGD:620847 | 6480464 | 2,4-dinitrotoluene affects the expression of CFLAR mRNA | CTD | PMID:21346803 | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein]; more ... | CTD | PMID:20850421 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CFLAR mRNA | CTD | PMID:20188158 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CFLAR mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:1347509 | 6480464 | Fenretinide inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | CTD | PMID:16230421 | 4-hydroxyphenyl retinamide | decreases reaction | ISO | RGD:1347509 | 6480464 | Fenretinide inhibits the reaction CFLAR protein | CTD | PMID:16230421 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:1347509 | 6480464 | decitabine affects the expression of CFLAR protein | CTD | PMID:18636160 | 5-fluorouracil | multiple interactions | ISO | RGD:1347509 | 6480464 | [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein; more ... | CTD | PMID:17045692 | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 more ... | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:16373718 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR protein | CTD | PMID:17045692 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR protein | CTD | PMID:16373718 more ... | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR protein | CTD | PMID:20876774 more ... | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR mRNA | CTD | PMID:17045692 PMID:20876774 | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR protein | CTD | PMID:16373718 more ... | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR protein | CTD | PMID:20876774 more ... | 5-fluorouracil | decreases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in decreased expression of CFLAR mRNA | CTD | PMID:20876774 PMID:17045692 | 5-fluorouracil | multiple interactions | ISO | RGD:1347509 | 6480464 | CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; more ... | CTD | PMID:20876774 | 5-fluorouracil | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to Fluorouracil | CTD | PMID:16373718 more ... | 5-fluorouracil | multiple interactions | ISO | RGD:1347509 | 6480464 | CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein] | CTD | PMID:16373718 | 5-fluorouracil | increases expression | ISO | RGD:1347509 | 6480464 | Fluorouracil results in increased expression of CFLAR mRNA | CTD | PMID:15152939 | 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1347509 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form | CTD | PMID:16709600 | acetylsalicylic acid | increases expression | ISO | RGD:1347509 | 6480464 | Aspirin results in increased expression of CFLAR mRNA | CTD | PMID:20457246 | actinomycin D | decreases expression | ISO | RGD:1347509 | 6480464 | Dactinomycin results in decreased expression of CFLAR protein | CTD | PMID:11234897 PMID:14601052 | actinomycin D | decreases expression | ISO | RGD:1347509 | 6480464 | Dactinomycin results in decreased expression of CFLAR protein | CTD | PMID:14601052 PMID:11234897 | adenosine | decreases expression | ISO | RGD:1347509 | 6480464 | Adenosine results in decreased expression of CFLAR mRNA; more ... | CTD | PMID:17303086 | adenosine | multiple interactions | ISO | RGD:1347509 | 6480464 | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA]; more ... | CTD | PMID:17303086 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CFLAR mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19731824 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19731824 PMID:19467017 | all-trans-retinoic acid | increases expression | ISO | RGD:1347509 | 6480464 | Tretinoin results in increased expression of CFLAR mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19467017 PMID:19731824 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1347509 | 6480464 | [Tretinoin co-treated with TGFB1 protein] results in increased expression of CFLAR protein | CTD | PMID:16242776 | amiodarone | decreases expression | ISO | RGD:620847 | 6480464 | Amiodarone results in decreased expression of CFLAR protein | CTD | PMID:21224497 | ammonium chloride | affects expression | ISO | RGD:620847 | 6480464 | Ammonium Chloride affects the expression of CFLAR mRNA | CTD | PMID:16483693 | baicalein | multiple interactions | EXP | | 6480464 | baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | CTD | PMID:20850421 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of CFLAR mRNA] | CTD | PMID:15034205 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CFLAR mRNA | CTD | PMID:15034205 | beta-carotene | increases expression | ISO | RGD:1347509 | 6480464 | beta Carotene results in increased expression of CFLAR mRNA | CTD | PMID:17034753 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA] | CTD | PMID:19850644 | bisphenol A | affects expression | ISO | RGD:1347509 | 6480464 | bisphenol A affects the expression of CFLAR mRNA | CTD | PMID:21826169 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CFLAR mRNA | CTD | PMID:22687993 | bisphenol A | decreases expression | ISO | RGD:1347509 | 6480464 | bisphenol A results in decreased expression of CFLAR mRNA | CTD | PMID:20678512 | cadmium dichloride | increases expression | ISO | RGD:620847 | 6480464 | Cadmium Chloride results in increased expression of CFLAR mRNA | CTD | PMID:19010381 | capsaicin | decreases expression | ISO | RGD:1347509 | 6480464 | Capsaicin results in decreased expression of CFLAR protein alternative form | CTD | PMID:19939880 | capsaicin | increases expression | ISO | RGD:1347509 | 6480464 | Capsaicin results in increased expression of CFLAR mRNA | CTD | PMID:19502594 | celecoxib | decreases expression | ISO | RGD:1347509 | 6480464 | celecoxib results in decreased expression of CFLAR | CTD | PMID:17145853 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | CTD | PMID:20938992 | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of CFLAR mRNA | CTD | PMID:18353800 | cisplatin | decreases expression | ISO | RGD:1347509 | 6480464 | Cisplatin results in decreased expression of CFLAR protein | CTD | PMID:14601052 PMID:20876774 | cisplatin | decreases expression | ISO | RGD:1347509 | 6480464 | Cisplatin results in decreased expression of CFLAR protein | CTD | PMID:20876774 PMID:14601052 | cisplatin | multiple interactions | ISO | RGD:1347509 | 6480464 | [Cisplatin results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | CTD | PMID:20876774 | cisplatin | decreases response to substance | EXP | | 6480464 | CFLAR protein results in decreased susceptibility to Cisplatin | CTD | PMID:20683665 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CFLAR mRNA | CTD | PMID:15681117 | coumestrol | decreases expression | ISO | RGD:1347509 | 6480464 | Coumestrol results in decreased expression of CFLAR mRNA | CTD | PMID:19167446 | curcumin | multiple interactions | ISO | RGD:1347509 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] | CTD | PMID:16219905 | curcumin | decreases expression | ISO | RGD:1347509 | 6480464 | Curcumin results in decreased expression of CFLAR protein | CTD | PMID:16173963 | cycloheximide | decreases expression | ISO | RGD:1347509 | 6480464 | Cycloheximide results in decreased expression of CFLAR protein | CTD | PMID:16951203 more ... | cycloheximide | decreases expression | ISO | RGD:1347509 | 6480464 | Cycloheximide results in decreased expression of CFLAR protein | CTD | PMID:16951203 more ... | cycloheximide | decreases expression | ISO | RGD:1347509 | 6480464 | Cycloheximide results in decreased expression of CFLAR protein | CTD | PMID:12663669 more ... | cycloheximide | decreases expression | ISO | RGD:1347509 | 6480464 | Cycloheximide results in decreased expression of CFLAR protein | CTD | PMID:16077199 more ... | cycloheximide | decreases expression | ISO | RGD:1347509 | 6480464 | Cycloheximide results in decreased expression of CFLAR protein alternative form | CTD | PMID:15924153 | dexamethasone | increases expression | ISO | RGD:1347509 | 6480464 | Dexamethasone results in increased expression of CFLAR | CTD | PMID:21244764 | dexamethasone | multiple interactions | ISO | RGD:1347509 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] | CTD | PMID:21244764 | diarsenic trioxide | decreases response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:16105982 | diarsenic trioxide | decreases expression | ISO | RGD:1347509 | 6480464 | arsenic trioxide results in decreased expression of CFLAR protein alternative form | CTD | PMID:16434995 | diarsenic trioxide | multiple interactions | ISO | RGD:1347509 | 6480464 | [arsenic trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein; more ... | CTD | PMID:17673311 | diarsenic trioxide | increases expression | ISO | RGD:1347509 | 6480464 | arsenic trioxide results in increased expression of CFLAR mRNA | CTD | PMID:22521957 | diarsenic trioxide | decreases expression | ISO | RGD:1347509 | 6480464 | arsenic trioxide results in decreased expression of CFLAR protein | CTD | PMID:16174796 PMID:16105982 | diarsenic trioxide | decreases expression | ISO | RGD:1347509 | 6480464 | arsenic trioxide results in decreased expression of CFLAR mRNA | CTD | PMID:16174796 | diarsenic trioxide | decreases expression | ISO | RGD:1347509 | 6480464 | arsenic trioxide results in decreased expression of CFLAR protein | CTD | PMID:16105982 PMID:16174796 | diclofenac | multiple interactions | ISO | RGD:1347509 | 6480464 | [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein | CTD | PMID:20237495 | diethyl maleate | decreases expression | ISO | RGD:620847 | 6480464 | diethyl maleate results in decreased expression of CFLAR mRNA | CTD | PMID:21161181 | dipyridamole | multiple interactions | ISO | RGD:1347509 | 6480464 | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA]; more ... | CTD | PMID:17303086 | doxorubicin | decreases expression | ISO | RGD:1347509 | 6480464 | Doxorubicin results in decreased expression of CFLAR protein | CTD | PMID:14601052 PMID:15897917 | doxorubicin | decreases expression | ISO | RGD:1347509 | 6480464 | Doxorubicin results in decreased expression of CFLAR protein | CTD | PMID:15897917 PMID:14601052 | doxorubicin | decreases expression | ISO | RGD:620847 | 6480464 | Doxorubicin results in decreased expression of CFLAR protein | CTD | PMID:15703961 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CFLAR protein | CTD | PMID:19429258 | etoposide | increases expression | ISO | RGD:1347509 | 6480464 | Etoposide results in increased expression of CFLAR protein | CTD | PMID:14601052 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | CTD | PMID:20938992 | hyaluronic acid | multiple interactions | ISO | RGD:1347509 | 6480464 | [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein | CTD | PMID:20237495 | hydrogen peroxide | increases expression | ISO | RGD:1347509 | 6480464 | Hydrogen Peroxide results in increased expression of CFLAR protein | CTD | PMID:18603805 | hydrogen peroxide | decreases expression | ISO | RGD:620847 | 6480464 | Hydrogen Peroxide results in decreased expression of CFLAR protein | CTD | PMID:16157298 | imatinib | multiple interactions | ISO | RGD:1347509 | 6480464 | [tetraarsenic tetrasulfide co-treated with imatinib] results in decreased expression of CFLAR mRNA | CTD | PMID:19208803 | indole-3-methanol | multiple interactions | ISO | RGD:1347509 | 6480464 | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | CTD | PMID:15811958 | indole-3-methanol | decreases expression | ISO | RGD:1347509 | 6480464 | indole-3-carbinol results in decreased expression of CFLAR | CTD | PMID:16082211 | indomethacin | multiple interactions | ISO | RGD:1347509 | 6480464 | Indomethacin inhibits the reaction [LTA protein results in increased expression of CFLAR protein] | CTD | PMID:17873517 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | CTD | PMID:20938992 | LY294002 | decreases expression | ISO | RGD:1347509 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein | CTD | PMID:12970779 | LY294002 | decreases expression | ISO | RGD:1347509 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein alternative form | CTD | PMID:16434995 | LY294002 | decreases expression | ISO | RGD:1347509 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein | CTD | PMID:12970779 PMID:21173233 | medroxyprogesterone acetate | multiple interactions | ISO | RGD:1347509 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form | CTD | PMID:16709600 | mifepristone | multiple interactions | ISO | RGD:1347509 | 6480464 | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] | CTD | PMID:12645856 | mifepristone | multiple interactions | ISO | RGD:1347509 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] | CTD | PMID:21244764 | mono(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein | CTD | PMID:20100735 | nickel sulfate | increases expression | ISO | RGD:1347509 | 6480464 | nickel sulfate results in increased expression of CFLAR mRNA | CTD | PMID:16780908 | ochratoxin A | decreases expression | ISO | RGD:620847 | 6480464 | ochratoxin A results in decreased expression of CFLAR mRNA | CTD | PMID:18417182 | oxaliplatin | affects response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein affects the susceptibility to oxaliplatin | CTD | PMID:16373718 | oxaliplatin | decreases expression | ISO | RGD:1347509 | 6480464 | oxaliplatin results in decreased expression of CFLAR protein | CTD | PMID:16373718 | oxaliplatin | multiple interactions | ISO | RGD:1347509 | 6480464 | CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] | CTD | PMID:16373718 | paclitaxel | decreases response to substance | ISO | RGD:1347509 | 6480464 | CFLAR protein results in decreased susceptibility to Paclitaxel | CTD | PMID:16080463 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CFLAR mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:1347509 | 6480464 | Acetaminophen results in decreased expression of CFLAR mRNA | CTD | PMID:21420995 | pemetrexed | decreases response to substance | ISO | RGD:1347509 | 6480464 | CFLAR results in decreased susceptibility to pemetrexed | CTD | PMID:21726997 | phenobarbital | affects expression | ISO | RGD:1347509 | 6480464 | Phenobarbital affects the expression of CFLAR mRNA | CTD | PMID:19159669 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CFLAR mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CFLAR mRNA | CTD | PMID:18445702 | quercetin | multiple interactions | ISO | RGD:1347509 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of CFLAR protein alternative form] | CTD | PMID:18980244 | quercetin | decreases expression | ISO | RGD:1347509 | 6480464 | Quercetin results in decreased expression of CFLAR protein alternative form | CTD | PMID:18980244 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CFLAR protein | CTD | PMID:17872969 | resveratrol | decreases cleavage | ISO | RGD:1347509 | 6480464 | resveratrol results in decreased cleavage of CFLAR protein | CTD | PMID:18222423 | resveratrol | multiple interactions | ISO | RGD:1347509 | 6480464 | TNFSF10 protein promotes the reaction [resveratrol results in decreased expression of CFLAR protein] | CTD | PMID:20097879 | resveratrol | decreases expression | ISO | RGD:1347509 | 6480464 | resveratrol results in decreased expression of CFLAR protein | CTD | PMID:20097879 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CFLAR mRNA | CTD | PMID:16081268 | rifampicin | multiple interactions | ISO | RGD:1347509 | 6480464 | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] | CTD | PMID:12645856 | rifampicin | increases expression | ISO | RGD:1347509 | 6480464 | Rifampin results in increased expression of CFLAR protein | CTD | PMID:11958592 | romidepsin | multiple interactions | ISO | RGD:1347509 | 6480464 | [romidepsin co-treated with bortezomib] results in decreased expression of CFLAR protein | CTD | PMID:18223231 | rosiglitazone | decreases expression | ISO | RGD:1347509 | 6480464 | rosiglitazone results in decreased expression of CFLAR mRNA | CTD | PMID:19731824 | rosiglitazone | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19731824 PMID:19467017 | rosiglitazone | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19467017 PMID:19731824 | rosiglitazone | decreases expression | ISO | RGD:1347509 | 6480464 | rosiglitazone results in decreased expression of CFLAR mRNA | CTD | PMID:19467017 PMID:19731824 | rosiglitazone | multiple interactions | ISO | RGD:1347509 | 6480464 | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | CTD | PMID:19731824 | rosiglitazone | decreases expression | ISO | RGD:1347509 | 6480464 | rosiglitazone results in decreased expression of CFLAR protein | CTD | PMID:18164688 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of CFLAR mRNA | CTD | PMID:19073995 | simvastatin | multiple interactions | ISO | RGD:1347509 | 6480464 | Simvastatin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | CTD | PMID:17277159 | simvastatin | decreases expression | ISO | RGD:1347509 | 6480464 | Simvastatin results in decreased expression of CFLAR protein alternative form | CTD | PMID:21910007 | simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CFLAR mRNA; more ... | CTD | PMID:19262002 | simvastatin | decreases expression | ISO | RGD:1347509 | 6480464 | Simvastatin results in decreased expression of CFLAR protein | CTD | PMID:18521906 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA | CTD | PMID:21641980 | tamoxifen | multiple interactions | ISO | RGD:1347509 | 6480464 | [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein modified form | CTD | PMID:17767197 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CFLAR mRNA | CTD | PMID:17484886 | thalidomide | decreases expression | ISO | RGD:1347509 | 6480464 | Thalidomide results in decreased expression of CFLAR protein | CTD | PMID:15986355 | trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CFLAR protein | CTD | PMID:17872969 | trans-resveratrol | decreases cleavage | ISO | RGD:1347509 | 6480464 | resveratrol results in decreased cleavage of CFLAR protein | CTD | PMID:18222423 | trans-resveratrol | multiple interactions | ISO | RGD:1347509 | 6480464 | TNFSF10 protein promotes the reaction [resveratrol results in decreased expression of CFLAR protein] | CTD | PMID:20097879 | trans-resveratrol | decreases expression | ISO | RGD:1347509 | 6480464 | resveratrol results in decreased expression of CFLAR protein | CTD | PMID:20097879 | trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CFLAR mRNA | CTD | PMID:16081268 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CFLAR mRNA | CTD | PMID:19448997 | trimethyltin | increases expression | EXP | | 6480464 | trimethyltin results in increased expression of CFLAR mRNA | CTD | PMID:21435392 | troglitazone | decreases expression | ISO | RGD:1347509 | 6480464 | troglitazone results in decreased expression of CFLAR protein | CTD | PMID:16820965 | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of CFLAR mRNA | CTD | PMID:17127020 | ursodeoxycholic acid | increases expression | ISO | RGD:1347509 | 6480464 | Ursodeoxycholic Acid analog results in increased expression of CFLAR protein | CTD | PMID:21146893 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CFLAR mRNA | CTD | PMID:21427059 | zerumbone | decreases expression | ISO | RGD:1347509 | 6480464 | zerumbone results in decreased expression of CFLAR mRNA | CTD | PMID:16007145 | |
Gene Ontology AnnotationsBiological Process











